Threshold Pharmaceuticals Inc. (THLD) Jumps 11.45% on January 20

Equities Staff |

Threshold Pharmaceuticals Inc. (THLD) was among the biggest gainers on the Russell 2000 for Wednesday January 20 as the stock popped 11.45% to $0.35, representing a gain of $0.0355 per share. Some 576,756 shares traded hands on 1,111 trades, compared with an average daily volume of 1.52 million shares out of a total float of 71.46 million. The stock opened at $0.30 and traded with an intraday range of $0.37 to $0.29.

After today's gains, Threshold Pharmaceuticals Inc. reached a market cap of $24.7 million. Threshold Pharmaceuticals Inc. has had a trading range between $5.28 and $0.30 over the last year, and it had a 50-day SMA of $1.93 and a 200-day SMA of $3.58.

Threshold Pharmaceuticals Inc is a biotechnology company. It is engaged in discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.

Threshold Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 64 employees. Its CEO is Harold E. Selick.

For a complete fundamental analysis analysis of Threshold Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for THLD. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.